Cresco Labs (CRLBF) Net Cash Flow (2020 - 2026)
Cresco Labs (CRLBF) posted Net Cash Flow of $467000.0 for Q1 2026, down 96.23% on a QoQ basis from $12.4 million in Q4 2025, and up 181.33% year-over-year from $166000.0 in Q1 2025.
Cresco Labs (CRLBF) Net Cash Flow (2020 - 2026) Analysis & Trends
Cresco Labs' Net Cash Flow history runs 7 years deep, the most recent figure standing at $467000.0 for Q1 2026.
- Quarterly Net Cash Flow rose 181.33% year-over-year to $467000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$79.7 million (down 415.82% YoY) and the FY2025 annual result came in at -$49.9 million, down 239.5% from the prior year.
- Net Cash Flow was $467000.0 for Q1 2026 at Cresco Labs, down from $12.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $40.6 million in Q3 2024 and bottomed at -$71.1 million in Q3 2025.
- A 5-year average of -$5.2 million and a median of -$4.5 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow sank 274.89% — and 2026, when it jumped 181.33%.
- Cresco Labs' Net Cash Flow stood at -$10.9 million in 2022, then jumped by 58.78% to -$4.5 million in 2023, then tumbled by 247.81% to -$15.6 million in 2024, then jumped by 179.67% to $12.4 million in 2025, then sank by 96.23% to $467000.0 in 2026.
- Business Quant data shows CRLBF's Net Cash Flow at $467000.0 in Q1 2026, $12.4 million in Q4 2025, and -$71.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 467,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 467,000.00 |
| Mar 31, 2026 | 467,000.00 |
| Dec 31, 2025 | 12.40 Mn |
| Dec 31, 2025 | 12.40 Mn |
| Sep 30, 2025 | -71.06 Mn |
| Sep 30, 2025 | -71.06 Mn |
| Jun 30, 2025 | -21.50 Mn |
| Jun 30, 2025 | -21.50 Mn |
| Mar 31, 2025 | 166,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | -15.56 Mn |
| Dec 31, 2024 | -15.56 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Dec 31, 2023 | -4.47 Mn |
| Dec 31, 2023 | -4.47 Mn |
| Sep 30, 2023 | 38.20 Mn |
| Sep 30, 2023 | 38.20 Mn |
| Dec 31, 2022 | -10.85 Mn |
| Dec 31, 2022 | -10.85 Mn |